Navigation Links
Zymes Omega Solutions Bottles and Launches the World's First Omega-3 Enhanced Water

OmegaChill, the world's first omega-3 enhanced water is available for immediate distribution

HASBROUCK HEIGHTS, N.J., March 16 /PRNewswire/ -- Zymes Omega Solutions, Inc., an affiliate of Zymes LLC, announces the successful bottling and launch of the world's first omega-3 enhanced water, OmegaChill ( This innovative new water uses Zymes' PTS technology to solubilize and stabilize fish-derived omega-3s. The resulting beverage delivers 50mg of EPA/DHA and has long-term shelf-stability at room temperature. The beverage also contains Vitamins C, E, B3, B6, B12, B5 and is naturally sweetened with Stevia with zero calories. The beverage is currently available in two flavors, Clearberry and Lemon-lime (lemon-lime contains electrolytes). OmegaChill will be on selected store shelves in the North East. Zymes Omega Solutions is seeking additional distribution partners for the enhanced waters and is licensing the technology for other food and beverage categories.

Zymes Omega Solutions uses Zymes water-solubilization technology, PTS(TM) to solubilize and stabilize omega-3s into nanomicelles with an average particle size of 25 nanometers, thus allowing for the formulation to be crystal clear in water. Zymes Omega Solutions, a leader in the solubility and stability of omega-3 fatty acids, offers formulation services and private label solutions in select categories. The technology is also available for licensing in select categories as well. Additionally, Zymes Omega Solutions has produced a dry powder formulation which is stable, water-soluble and can be used for a number of product applications.

"It is extremely gratifying to be launching the world's first omega-3 enhanced water," said Benjamin D. Mamola, Chief Executive Officer of Zymes Omega Solutions Inc. "In addition to the enhanced water, our company is developing other omega-3 enhanced products including omega-3 kids' drink pouches, ready-to-eat gelatins, granola bars, dry stick packs and high concentrate omega-3 shots. We look forward to becoming the new standard in the delivery of omega-3s for food and beverage products world-wide."

The solubilization compound, PTS, is being manufactured at scale by Albemarle, one of Zymes' manufacturing partners. Albemarle's commercial scale and quality is helping satisfy the increasing demand of PTS/Omega-3s for food and beverage applications. Zymes Omega Solutions' PTS/omega-3s is GRAS-affirmed for food and beverage applications. Zymes Omega Solutions' holds the world-wide exclusive rights to PTS/omega-3s for all food and beverages.

About Zymes Omega Solutions:

Zymes Omega Solutions Inc., a Delaware Corporation and affiliate of Zymes LLC, is a bio-science company that combines science and technology to create and enable Omega-3 fortified consumer products that promote health and wellness. Based in Hasbrouck Heights, NJ, Zymes Omega Solutions holds the world-wide exclusive rights for the use of PTS for omega-3s for food, beverage and dietary supplements. For more information, email, or see: and

SOURCE Zymes Omega Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Albemarle Manufactures Zymes PTS, the Lead Compound in a Breakthrough Solubilization Technology
2. Novozymes Reports Strong 2008 Results
3. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
4. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
5. Genencor Appoints New Executive Vice President - Technical Enzymes
6. Novozymes Launches Enzyme to Reduce Acrylamide in Food
7. Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes
8. OmegaGenesis Announces Angiogenesis Application Collaboration
9. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
10. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
11. Martek Announces Settlement of OmegaTech Milestone Litigation
Post Your Comments:
(Date:11/30/2015)... Epigenetics Corp. ("Zenith" or the "Company") today announced that it ... Board of Directors to replace Dr. Peter Johann . ... as co-founder of Resverlogix, with expertise in the fields of ... --> Dr. Wong remarked, "I am very excited to ... expertise in epigenetics and the advanced stage of the R&D ...
(Date:11/30/2015)... ... November 30, 2015 , ... Imagine Exhibitions and Universal Partnerships ... opening in March 2016 at Melbourne Museum in Melbourne, Australia. Immediately following the ... American tour dates. The Exhibition is based on Universal Pictures’ Jurassic World, one ...
(Date:11/30/2015)... 2015 Human Longevity, Inc. (HLI), the genomics-based, ... Cypher Genomics, Inc., a leading genome informatics company offering ... solutions. The San Diego -based company ... CEO and Co-founder, Ashley Van Zeeland , Ph.D., who ... details of the deal were not disclosed. ...
(Date:11/30/2015)... , Nov. 30, 2015  HUYA Bioscience International, ... China,s pharmaceutical innovations, today announced it has ... Development Fund (KDDF) to foster collaboration between KDDF and ... and commercialization of healthcare products for the global market. ... an important source of new innovative preclinical and clinical ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):